{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:01:20Z","timestamp":1789599680108,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.1093\/ndt\/gfw097","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T20:58:57Z","timestamp":1463518737000},"page":"1755-1758","source":"Crossref","is-referenced-by-count":8,"title":["Effect of resveratrol on progression of polycystic kidney disease: a case of\n          cautious optimism"],"prefix":"10.1093","volume":"31","author":[{"given":"Hamid","family":"Moradi","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, University of California, Irvine, 333 City Blvd West, Orange, CA 92868, USA"},{"name":"Long Beach VA Healthcare System, Nephrology Section, Long Beach, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[{"name":"Long Beach VA Healthcare System, Nephrology Section, Long Beach, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"2019053109102653000_GFW097C1","article-title":"2011 Annual Data\n              Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United\n              States","author":"United States Renal Data System","year":"2011"},{"key":"2019053109102653000_GFW097C2","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant\n            polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin\n            Invest"},{"key":"2019053109102653000_GFW097C3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"2019053109102653000_GFW097C4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney\n            disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev\n            Nephrol"},{"key":"2019053109102653000_GFW097C5","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1523-1755.2004.66003.x","article-title":"Comparison between siblings and twins\n            supports a role for modifier genes in ADPKD","volume":"66","author":"Persu","year":"2004","journal-title":"Kidney\n              Int"},{"key":"2019053109102653000_GFW097C6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1573402111309010008","article-title":"Experimental therapies and ongoing clinical trials to slow down\n            progression of ADPKD","volume":"9","author":"Irazabal","year":"2013","journal-title":"Curr Hypertens\n            Rev"},{"key":"2019053109102653000_GFW097C7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ki.1991.87","article-title":"Cytokines in fluids from polycystic\n            kidneys","volume":"39","author":"Gardner","year":"1991","journal-title":"Kidney Int"},{"key":"2019053109102653000_GFW097C8","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","article-title":"Increased renal expression of monocyte\n            chemoattractant protein-1 and osteopontin in ADPKD in rats","volume":"60","author":"Cowley","year":"2001","journal-title":"Kidney Int"},{"key":"2019053109102653000_GFW097C9","first-page":"526A","article-title":"Urinary monocyte chemotactic protein-1 (MCP1)\n            predicts progression in autosomal dominant polycystic kidney disease (ADPKD). Abstract\n            F-PO1814","volume":"21","author":"Grantham","year":"2010","journal-title":"J Am Soc\n            Nephrol"},{"key":"2019053109102653000_GFW097C10","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","article-title":"Urinary excretion of monocyte chemoattractant\n            protein-1 in autosomal dominant polycystic kidney disease","volume":"14","author":"Zheng","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2019053109102653000_GFW097C11","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic\n            kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J Am Soc\n            Nephrol"},{"key":"2019053109102653000_GFW097C12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease\n            progression","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney\n            Int"},{"key":"2019053109102653000_GFW097C13","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1172\/JCI80467","article-title":"Macrophage migration inhibitory factor\n            promotes cyst growth in polycystic kidney disease","volume":"125","author":"Chen","year":"2015","journal-title":"J\n              Clin Invest"},{"key":"2019053109102653000_GFW097C14","doi-asserted-by":"crossref","first-page":"963217","DOI":"10.1155\/2013\/963217","article-title":"Resveratrol: why is it a promising therapy\n            for chronic kidney disease patients?","volume":"2013","author":"Saldanha","year":"2013","journal-title":"Oxid Med Cell\n              Longev"},{"key":"2019053109102653000_GFW097C15","doi-asserted-by":"crossref","first-page":"803971","DOI":"10.1155\/2015\/803971","article-title":"An organ system approach to explore the antioxidative, anti-inflammatory,\n            and cytoprotective actions of resveratrol","volume":"2015","author":"Malhotra","year":"2015","journal-title":"Oxid Med Cell\n              Longev"},{"key":"2019053109102653000_GFW097C16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nut.2015.08.017","article-title":"Beneficial action of resveratrol: how and\n            why?","volume":"32","author":"Diaz-Gerevini","year":"2016","journal-title":"Nutrition"},{"key":"2019053109102653000_GFW097C17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in\n            chronic kidney disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr Opin\n              Nephrol Hypertens"},{"key":"2019053109102653000_GFW097C18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to\n            ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int"},{"key":"2019053109102653000_GFW097C19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbadis.2011.03.008","article-title":"Resveratrol protects diabetic kidney by attenuating\n            hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1\n            signaling","volume":"1812","author":"Palsamy","year":"2011","journal-title":"Biochim Biophys\n            Acta"},{"key":"2019053109102653000_GFW097C20","doi-asserted-by":"crossref","first-page":"F1067","DOI":"10.1152\/ajprenal.00005.2010","article-title":"Role of the energy sensor AMP-activated\n            protein kinase in renal physiology and disease","volume":"298","author":"Hallows","year":"2010","journal-title":"Am J\n              Physiol Renal Physiol"},{"key":"2019053109102653000_GFW097C21","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase\n            (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci\n              USA"},{"key":"2019053109102653000_GFW097C22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/ki.2015.157","article-title":"Sirtuin and metabolic kidney disease","volume":"88","author":"Wakino","year":"2015","journal-title":"Kidney Int"},{"key":"2019053109102653000_GFW097C23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1681\/ASN.2013010069","article-title":"Endothelial sirtuin 1 deficiency perpetrates\n            nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to\n            fibrosis of vascular senescence","volume":"25","author":"Vasko","year":"2014","journal-title":"J Am Soc\n              Nephrol"},{"key":"2019053109102653000_GFW097C24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.mce.2014.08.014","article-title":"Polydatin promotes Nrf2-ARE anti-oxidative\n            pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and\n            transforming growth factor-\u03b21 in rat glomerular messangial cells","volume":"399","author":"Huang","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"2019053109102653000_GFW097C25","article-title":"Sirtuin 1 promotes hyperoxia-induced lung\n            epithelial death independent of NRF2 activation","author":"Potteti","year":"2015","journal-title":"Am J\n              Respir Cell Mol Biol"},{"key":"2019053109102653000_GFW097C26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/ndt\/gfw058","article-title":"Resveratrol delays polycystic kidney disease\n            progression through attenuation of nuclear factor \u03baB-induced\n            inflammation","volume":"31","author":"Wu","year":"2016","journal-title":"Nephrol Dial\n            Transplant"},{"key":"2019053109102653000_GFW097C27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.freeradbiomed.2015.04.022","article-title":"Dose-dependent deleterious and salutary\n            actions of the Nrf2 inducer dh404 in chronic kidney disease","volume":"86","author":"Vaziri","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"2019053109102653000_GFW097C28","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in\n            autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin\n              Invest"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/31\/11\/1755\/28752418\/gfw097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T09:10:45Z","timestamp":1559293845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/31\/11\/1755\/2469187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,5,17]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw097","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11]]},"published":{"date-parts":[[2016,5,17]]}}}